GlassScriptPhysician profile
Lisa Bonin
NPI 1235177601
$754.41
in general payments reported to CMS, 2019-2025
17 companies · $19.94 in 2025
The $19.94 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $314 · 2023: $280 · 2024: $141 · 2025: $19.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $441.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $440.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $134.87 | 2022-2024 | |
| Lilly USA, LLC | $101.23 | 2022-2024 | Mounjaro, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $88.74 | 2022 | |
| Amgen INC. | $67.01 | 2022-2024 | Otezla, Repatha |
| Novo Nordisk INC | $55.79 | 2022 | |
| Janssen Biotech, INC. | $48.19 | 2022 | |
| Pfizer INC. | $47.96 | 2022-2025 | |
| Exact Sciences Corporation | $46.68 | 2023 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $31.83 | 2023 | Trelegy Ellipta |
| Sumitomo Pharma America, INC. | $27.14 | 2024 | Gemtesa |
| Paratek Pharmaceuticals, INC. | $20.76 | 2024 | Nuzyra |
| Phathom Pharmaceuticals, INC. | $17.47 | 2024 | Voquezna |
| Idorsia Pharmaceuticals US INC | $14.63 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.32 | 2024 | Xifaxan |
| Astrazeneca Pharmaceuticals LP | $13.28 | 2024 | Farxiga |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $13.22 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Bonin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.